![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an...
Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the...
Clinical Trials
Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that it has...
Clinical Trials
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a...
Clinical Trials
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment...
Clinical Trials
Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients
Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19....
Clinical Trials
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment
Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read